A detailed history of Truist Financial Corp transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Truist Financial Corp holds 25,827 shares of STVN stock, worth $556,313. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,827
Previous 26,034 0.8%
Holding current value
$556,313
Previous $477,000 8.18%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$17.98 - $22.02 $3,721 - $4,558
-207 Reduced 0.8%
25,827 $516,000
Q2 2024

Aug 20, 2024

BUY
$16.93 - $31.33 $140,874 - $260,696
8,321 Added 46.98%
26,034 $477,000
Q1 2024

May 10, 2024

BUY
$25.34 - $34.28 $7,652 - $10,352
302 Added 1.73%
17,713 $568,000
Q4 2023

Feb 02, 2024

SELL
$25.21 - $34.66 $26,294 - $36,150
-1,043 Reduced 5.65%
17,411 $475,000
Q3 2023

Nov 14, 2023

BUY
$26.91 - $35.49 $11,517 - $15,189
428 Added 2.37%
18,454 $548,000
Q2 2023

Aug 01, 2023

BUY
$25.15 - $32.86 $34,732 - $45,379
1,381 Added 8.3%
18,026 $583,000
Q1 2023

May 05, 2023

BUY
$17.5 - $25.9 $61,915 - $91,634
3,538 Added 26.99%
16,645 $431,000
Q4 2022

Feb 17, 2023

SELL
$13.95 - $19.28 $45,072 - $62,293
-3,231 Reduced 19.78%
13,107 $235,000
Q3 2022

Oct 26, 2022

SELL
$14.66 - $18.3 $56,133 - $70,070
-3,829 Reduced 18.99%
16,338 $277,000
Q2 2022

Jul 22, 2022

BUY
$14.1 - $20.26 $3,369 - $4,842
239 Added 1.2%
20,167 $319,000
Q1 2022

Apr 22, 2022

SELL
$15.23 - $21.47 $4,188 - $5,904
-275 Reduced 1.36%
19,928 $397,000
Q4 2021

Feb 14, 2022

BUY
$21.65 - $27.0 $42,823 - $53,406
1,978 Added 10.85%
20,203 $454,000
Q3 2021

Nov 05, 2021

BUY
$19.51 - $28.7 $355,569 - $523,057
18,225 New
18,225 $461,000

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.7B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.